cas 1190314-33-0|| where to buy 2-Cyclobutyloxazole-4-carboxylic acid

Produktname:2-Cyclobutyloxazole-4-carboxylic acid

IUPAC Name:2-cyclobutyl-1,3-oxazole-4-carboxylic acid

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM488439-1g	in stock	ǕșǕ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1190314-33-0 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1190314-33-0; Molekulare Formel:C8H9NO3; Schmelzpunkt:-; SMILES-Code:O=C(C1=COC(C2CCC2)=N1)O; Dichte:

: Katalognummer:CM488439; Molekulargewicht:167.16; Siedepunkt:; Mdl-Nr.:MFCD12962564; Lagerung:

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.